Chu de Reims-Hopital Maison Blanche

Reims 51092

0 studies enrolling now · 7 studies all time

What they study most

Chronic Kidney Disease, Diabetes Mellitus, Type 2, Early Alzheimer's Disease, Early Alzheimer´s Disease, Emphysema, Idiopathic Pulmonary Fibrosis, Obesity, Type 2 Diabetes

Studies at this site

• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo — Completed
• A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial) — Completed
• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009) — Stopped early
• Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study — Stopped early